When Pfizer Inc. (NYSE:PFE) and Allergan Plc (NYSE:AGN) announced their proposed merger deal collapsed on April 6, so too did the hopes of several influential hedge fund managers who staked much capital on its success, but some investors have seen benefits.
Both companies had been working toward the $160 billion merger since December, which would have re-introduced a focus on dermatology to Pfizer and created the world’s largest drug company. It would also have famously moved the headquarters to Ireland, where the corporate tax rate is 18% compared to 35% in the U.S.
|